Brief: Rallybio Reports Third Quarter Results
07/11/2022 14:01
Nov 7 (Reuters) - Rallybio Corp RLYB.O :
* RALLYBIO REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS
* Q3 LOSS PER SHARE $0.60
* PRELIMINARY RESULTS FROM PHASE 1B STUDY OF RLYB212 SHOWED
RAPID
AND COMPLETE ELIMINATION OF TRANSFUSED PLATELETS IN SUBJECTS
* Q3 EARNINGS PER SHARE VIEW $-0.54 -- REFINITIV IBES DATA
* PROOF-OF-CONCEPT DATA EXPECTED IN 1Q 2023
Source text for Eikon: ID:nBwbr0ksDa
Further company coverage: RLYB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Rallybio
See all newsNASDAQ RESUMED AT 08:48 AM
Brief: Rallybio Corporation And Avenzo Therapeutics Announce Merger Agreement To Advance Next-Generation Oncology Therapies And $215 Million Concurrent Private Placement
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:55 AM
U.S. STOCKS ON THE MOVE-Mirum Pharma
U.S. STOCKS ON THE MOVE-Mirum Pharma, eBay, FedEx